Breaking News
March 24, 2018 - Waning Vaccine Protection May Be Driving Rise in U.S. Mumps Cases
March 24, 2018 - Folic Acid in Utero Tied to Food Allergy Risk
March 24, 2018 - Trial shows safety of drugs for irregular heartbeat patients undergoing treatment
March 24, 2018 - Penn State psychologists shed light on false memories in older adults
March 24, 2018 - Patients who self-discharge should be viewed more positively, say researchers
March 24, 2018 - Wearable brain scanner enables brain imaging whilst moving
March 24, 2018 - Trump Signs $1.3 Trillion Spending Bill, Averts Shutdown
March 24, 2018 - Two drugs prevent heart problems in breast cancer patients
March 24, 2018 - Research provides better understanding of how some cancer cells resist treatment
March 24, 2018 - Certain nutrients found in food may help reduce symptoms of psychotic illness
March 24, 2018 - AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
March 24, 2018 - AHRQ Is in Trouble | Medpage Today
March 24, 2018 - Could a pap test spot more than just cervical cancer?
March 24, 2018 - Men have greater hospital readmission risk following firearm injury, study shows
March 24, 2018 - Pediatric psychologist shares 11 warning signs of childhood depression
March 24, 2018 - OncoBreak: ‘I Was Normal Once’; Ending Cervical Cancer; Mammo Controversy
March 24, 2018 - Gum Disease by the Numbers
March 24, 2018 - Studies show tool can identify individual needs, supports to help youths with autism, intellectual disabilities
March 24, 2018 - Study reveals cause of extreme nausea in pregnancy
March 24, 2018 - New findings highlight need to reconsider cervical cancer screening guidelines
March 24, 2018 - Smartwatch App Might Help Detect A-Fib
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Obesity and severe obesity continue to rise among U.S. adults
March 24, 2018 - Missed hospital appointments increase after spring clock change in the UK
March 24, 2018 - Researchers explore ways to manage and prevent falls in older adults with dementia
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - NUST MISIS researchers produce elastic metal rods for scoliosis treatment
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
March 23, 2018 - 24-Hr Paging Cuts ED Visits for Kids with Endocrine Issues
March 23, 2018 - The brain learns completely differently than we’ve assumed since the 20th century
March 23, 2018 - Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
March 23, 2018 - Stony Brook Medicine expert provides tips for healthy diet to decrease cancer risk
March 23, 2018 - New findings could have revolutionary impact on quality of life of older people
March 23, 2018 - Restoring enzyme may help reverse effects of vascular aging, study shows
March 23, 2018 - Protein profiling reveals new prostate cancer mechanisms
March 23, 2018 - Depression may be linked to increased risk of atrial fibrillation
Antihypertensive Use At Delivery Rising in Preeclampsia

Antihypertensive Use At Delivery Rising in Preeclampsia

image_pdfDownload PDFimage_print

Action Points

  • Use of antihypertensive medications during delivery among women with preeclampsia increased significantly over the past decade
  • The rate of stroke in patients with preeclampsia declined from 6.6 per 10,000 deliveries in 2006-2008 to 3.5 per 10,000 deliveries in 2012-2014

Use of antihypertensive medications during delivery among women with preeclampsia increased significantly over the past decade, an administrative database study showed.

Almost half of patients with preeclampsia received antihypertensive medication in 2015 — a substantial increase versus 2006, when only 37.8% received such medication (P<0.01), reported Kristen Cleary, MD, of Columbia University in New York City, and colleagues.

Moreover, the rate of stroke in patients with preeclampsia declined from 6.6 per 10,000 deliveries in 2006-2008 to 3.5 per 10,000 deliveries in 2012-2014 (P=0.02), the authors wrote in Obstetrics and Gynecology.

They noted that the American College of Obstetricians and Gynecologists’ (ACOG) Task Force on Hypertension in Pregnancy supports administering antihypertensive agents for preeclampsia with severe features with sustained blood pressure of 160 mm Hg or 110 mm Hg systolic and diastolic, respectively. First-line agents for acute hypertension in this population include IV beta-blocker labetalol, IV vasodilator hydralazine, and oral calcium channel blocker nifedipine, they said.

But the authors added that there is “limited research on how practice patterns are changing” and to what degree antihypertensive agents are being used to treat hypertensive episodes, as well as little data on how they are associated with improved outcomes.

They looked at data from the Perspective database to determine use of antihypertensive drugs dispensed during delivery hospitalizations complicated by preeclampsia. The database includes patient demographics, hospital characteristics, discharge diagnosis codes, and medications and devices administered during acute care hospitalizations. Notably, the authors said discharges in the Perspective database account for “approximately 15% of all inpatient hospital stays annually in the United States.”

From January 2006 to March 2015, researchers examined data from 239,000 women admitted for a delivery hospitalization with an associated preeclampsia diagnosis. Based on ICD-9-CM codes, they were categorized as having mild (n=126,000), severe (n=81,000), or superimposed (n=32,000) preeclampsia.

The authors noted that over the course of the study, the portion of patients increased for both severe preeclampsia (36.9% of cases in 2015 versus 30.9% in 2006) and superimposed preeclampsia (15.7% versus 10.3%, respectively). Notably, superimposed preeclampsia was more common in the southern region of the U.S., among black women, and among women ages 35 and older.

Use of individual hypertensive agents increased over the course of the study from 2006 to 2014, as well:

  • Oral labetalol (20.3% to 31.4%)
  • IV labetalol (13.3% to 21.4%)
  • Hydralazine (12.8% to 16.9%)
  • Nifedipine (15.0% to 18.2%)
  • More than one medication (16.5% to 25.8%)

Adjusted analyses found that the likelihood of antihypertensive use rose (adjusted RR 1.19, 95% CI 1.12-1.27 in 2015 versus 2006). Severe and superimposed preeclampsia were associated with the largest increase in likelihood of antihypertensive medication use (adjusted RR 2.19, 95% CI 2.12-2.26, and adjusted RR 2.32, 95% CI 2.23-2.41, respectively). The authors said that other significant factors included black race (adjusted RR 1.30 versus white race, 95% CI 1.27-1.33) and maternal age 35 years or older (adjusted RR 1.17 versus age 18-24, 95% CI 1.15-1.19).

Not surprisingly, the rate of stroke was highest among patients with severe preeclampsia, but that declined sharply from 13.5 per 10,000 deliveries in 2006-2008 to 6.0 per 10,000 deliveries in 2012-2014.

Limitations to the study included use of only administrative data and lack of information on how individual hospital factors may have impacted the results. In addition, though the data showed that a drug was ordered and administered, the authors could not determine if it occurred in a “timely, optimal fashion” and if treatment in a specific time interval improved outcomes. Nor could they not establish a causal relationship between antihypertensive medication and risk for stroke.

Cleary disclosed no conflicts of interest.

One co-author disclosed support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner


Tagged with:

About author

Related Articles